Establishment Labs Holdings Inc (ESTA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Establishment Labs Holdings Inc (ESTA) has a cash flow conversion efficiency ratio of -0.292x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.31 Million) by net assets ($14.78 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Establishment Labs Holdings Inc - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Establishment Labs Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read ESTA liabilities breakdown for a breakdown of total debt and financial obligations.
Establishment Labs Holdings Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Establishment Labs Holdings Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Orbia Advance Corporation S.A.B. de C.V
F:4FZ
|
0.134x |
|
Hamilton Insurance Group, Ltd.
NYSE:HG
|
0.037x |
|
Banco do Nordeste do Brasil S.A
SA:BNBR3
|
-0.200x |
|
TietoEVRY Corp
HE:TIETO
|
0.149x |
|
Klaviyo, Inc.
NYSE:KVYO
|
0.078x |
|
Nichidenbo Corp
TW:3090
|
0.017x |
|
Jenoptik AG
F:JEN
|
0.054x |
|
Viet Nam International Commercial Joint Stock Bank
VN:VIB
|
0.007x |
Annual Cash Flow Conversion Efficiency for Establishment Labs Holdings Inc (2016–2025)
The table below shows the annual cash flow conversion efficiency of Establishment Labs Holdings Inc from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Establishment Labs Holdings Inc worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $23.55 Million | $-50.89 Million | -2.161x | -96.10% |
| 2024-12-31 | $53.09 Million | $-58.52 Million | -1.102x | +77.10% |
| 2023-12-31 | $18.39 Million | $-88.51 Million | -4.812x | -175.50% |
| 2022-12-31 | $-8.19 Million | $-52.17 Million | 6.373x | +1274.55% |
| 2021-12-31 | $50.74 Million | $-27.53 Million | -0.543x | -225.14% |
| 2020-12-31 | $74.96 Million | $-12.51 Million | -0.167x | +77.95% |
| 2019-12-31 | $39.61 Million | $-29.98 Million | -0.757x | -55.21% |
| 2018-12-31 | $69.48 Million | $-33.88 Million | -0.488x | -107.65% |
| 2017-12-31 | $-5.01 Million | $-31.97 Million | 6.377x | +1081.74% |
| 2016-12-31 | $-26.43 Million | $-14.27 Million | 0.540x | -- |
About Establishment Labs Holdings Inc
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products… Read more